Skip to Content

12.5/500 322M (Kazano 12.5 mg / 500 mg)

Generic Name: alogliptin/metformin

Pill imprint 12.5/500 322M has been identified as Kazano 12.5 mg / 500 mg.

Kazano is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kazano 12.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Kazano
Generic Name:
alogliptin/metformin
Imprint:
12.5/500 322M
Strength:
12.5 mg / 500 mg
Color:
Yellow
Shape:
Rectangle
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide